Canani Roberto Berni, Castaldo Giuseppe, Bacchetta Rosa, Martín Martín G, Goulet Olivier
Department of Translational Medical Science, University of Naples Federico II, Via S. Pansini 5 80131, Naples, Italy.
Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via S. Pansini 5 80131, Naples, Italy.
Nat Rev Gastroenterol Hepatol. 2015 May;12(5):293-302. doi: 10.1038/nrgastro.2015.44. Epub 2015 Mar 17.
Congenital diarrhoeal disorders (CDDs) represent an evolving web of rare chronic enteropathies, with a typical onset early in life. In many of these conditions, severe chronic diarrhoea represents the primary clinical manifestation, whereas in others diarrhoea is only a component of a more complex multi-organ or systemic disorder. Typically, within the first days of life, diarrhoea leads to a life-threatening condition highlighted by severe dehydration and serum electrolyte abnormalities. Thus, in the vast majority of cases appropriate therapy must be started immediately to prevent dehydration and long-term, sometimes severe, complications. The number of well-characterized disorders attributed to CDDs has gradually increased over the past several years, and many new genes have been identified and functionally related to CDDs, opening new diagnostic and therapeutic perspectives. Molecular analysis has changed the diagnostic scenario in CDDs, and led to a reduction in invasive and expensive procedures. Major advances have been made in terms of pathogenesis, enabling a better understanding not only of these rare conditions but also of more common diseases mechanisms.
先天性腹泻疾病(CDDs)是一系列不断演变的罕见慢性肠病,通常在生命早期发病。在许多这类疾病中,严重慢性腹泻是主要临床表现,而在其他疾病中,腹泻只是更复杂的多器官或全身性疾病的一部分。通常在出生后的头几天内,腹泻会导致危及生命的状况,其特征为严重脱水和血清电解质异常。因此,在绝大多数情况下,必须立即开始适当治疗,以防止脱水以及长期的、有时是严重的并发症。在过去几年中,归因于CDDs的特征明确的疾病数量逐渐增加,许多新基因已被鉴定并与CDDs存在功能关联,从而开辟了新的诊断和治疗前景。分子分析改变了CDDs的诊断局面,并减少了侵入性和昂贵的检查程序。在发病机制方面已取得重大进展,这不仅有助于更好地理解这些罕见疾病,还能更好地理解更常见疾病的机制。